Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NKE vs GSK✓SelectedUSD · GSKNKE vs GSK performance historyLatest closeAs of+0.71%11/16
Stock and ETF performance explorer

NKE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6,138.5%
GSK return
+1,741.1%
Excess return
+4,397.4%
Maximum drawdown
-79.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-0.1%+0.8%+0.7%
7D-4.1%-1.3%-2.8%-3.6%
30D+3.0%+2.7%+0.3%+2.2%
3M-5.1%+2.7%-7.8%-5.9%
6M-6.8%+3.3%-10.2%-8.0%
YTD-38.4%+6.5%-44.8%-39.9%
1Y-38.4%+10.7%-49.1%-40.7%
3Y-61.9%+64.4%-126.2%-68.4%
5Y-75.6%+46.7%-122.3%-79.2%
10Y-12.7%+109.4%-122.0%-34.3%
All+6,138.5%+1,741.1%+4,397.4%+1,912.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling